COMMUNIQUÉS West-GlobeNewswire

Revolution Medicines to Present at 43rd Annual J.P. Morgan Healthcare Conference
06/01/2025
REDWOOD CITY, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel targeted therapies for patients with RAS-addicted cancers, today [...]
ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
06/01/2025
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 43rd Annual [...]
CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update
06/01/2025
- Encouraging progress supports near-term focus on lead wholly-owned program, CX-2051 (EpCAM PROBODY ® ADC). Initial Phase 1a clinical data in advanced metastatic colorectal cancer (CRC) are anticipated in the first [...]
Oncocyte Expands Market Opportunity for VitaGraft™ Kidney
06/01/2025
Medicare coverage expanded following study showing that monitoring with Oncocyte’s assay significantly reduces time to rejection diagnosis in patients with newly developed donor-specific antibodies (DSA) MolDX confirms [...]
Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference
06/01/2025
LONDON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that it will present at the 43 rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 [...]
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/01/2025
WESTLAKE VILLAGE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
Cytokinetics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
06/01/2025
SOUTH SAN FRANCISCO, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to present at the 43 rd [...]
ACELYRIN, INC. Announces Additional Phase 2 Data and Phase 3 Program Design for Lonigutamab in Thyroid Eye Disease
06/01/2025
Totality of data observed with subcutaneous lonigutamab in Thyroid Eye Disease (TED) patients demonstrate potential for efficacy in line with standard of care and a more favorable safety profile Conducted positive end [...]
MESA LABS DECLARES QUARTERLY DIVIDEND
06/01/2025
LAKEWOOD, Colo., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0 [...]
Bright Peak Therapeutics to Participate in 43rd Annual J.P. Morgan Healthcare Conference
06/01/2025
BASEL, Switzerland and SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, [...]
SAFE - Assemblée générale mixte du 30 décembre 2024
06/01/2025
Assemblée générale mixte du 30 décembre 2024 Fleurieux-sur-l’Arbresle - France - le 6 janvier 2025 à 19h . L’assemblée générale des actionnaires de Safe réunie le 30 décembre 2024 à Fleurieux-sur-l’Arbresle, sous la [...]
UPDATE – LB Pharmaceuticals Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
06/01/2025
NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia, today [...]
Preliminary Financial Figures for the 2024 Fiscal Year
06/01/2025
January 6, 2025 Announcement no. 01 Preliminary Financial Figures for the 2024 Fiscal Year COPENHAGEN, DENMARK, January 6, 2025, (GLOBE NEWSWIRE) – BioPorto A/S CVR-no. 17500317 (BioPorto or Company) (CPH:BIOPOR), an in [...]
UPDATE - Basecamp Research Appoints John Finn, Ph.D., as CSO, Expands Internationally with U.S. Lab and Offices, and Builds One of Europe's Largest Industrial Supercomputers with NVIDIA Accelerated Computing
06/01/2025
Finn, an industry leader in the field of cell and gene therapy, will lead company’s efforts to advance groundbreaking approaches to programmable genetic medicines Office and lab in Kendall Square (Cambridge, Mass.) to [...]
Ose Immunotherapeutics : Informations relatives au nombre total de droits de vote et d’actions composant le capital
06/01/2025
Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 6 janvier 2025 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement [...]
Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference
06/01/2025
Saint Herblain (France), January 6, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announces that members of its management team will meet one-on-one with existing shareholders [...]
Valneva rencontrera des investisseurs lors de la J.P. Morgan Healthcare Conference
06/01/2025
Saint Herblain (France), le 6 janvier 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui que des membres de son équipe dirigeante rencontreront des [...]
EUROAPI welcomes the French Minister for Health and Access to Healthcare Yannick Neuder and the French Minister for Industry and Energy Marc Ferracci to its Puy-de-Dôme site
06/01/2025
Press Release A tour of Vertolaye manufacturing and storage facilities highlighted EUROAPI’s long-term commitment to health sovereignty Paris and Vertolaye - January 6, 2025 – The French Minister for Health and Access [...]
EUROAPI accueille le ministre de la Santé et de l’Accès aux soins Yannick Neuder et le ministre de l’Industrie et de ’Energie Marc Ferracci sur son site du Puy-de-Dôme
06/01/2025
Communiqué de presse La visite des unités de fabrication et de stockage de Vertolaye a permis de rappeler l’engagement de long terme d’EUROAPI en faveur de la souveraineté sanitaire Paris et Vertolaye – Le 6 janvier [...]

Pages